D. W. Galvani

425 total citations
25 papers, 254 citations indexed

About

D. W. Galvani is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, D. W. Galvani has authored 25 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Hematology and 9 papers in Genetics. Recurrent topics in D. W. Galvani's work include Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). D. W. Galvani is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). D. W. Galvani collaborates with scholars based in United Kingdom and Australia. D. W. Galvani's co-authors include John C. Cawley, A.B.W. Nethersell, Sylvie Delikat, Steven W. Edwards, Mirko Zuzel, Gordon Lowe, Simon Griffiths, Yushe Dang, Ross Harris and Fiona L. Watson and has published in prestigious journals such as Biochemical and Biophysical Research Communications, British Journal of Haematology and Lara D. Veeken.

In The Last Decade

D. W. Galvani

24 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. W. Galvani United Kingdom 11 108 106 79 45 45 25 254
M Teramura Japan 10 111 1.0× 228 2.2× 100 1.3× 63 1.4× 66 1.5× 20 395
Alexander Sternberg United Kingdom 7 56 0.5× 203 1.9× 107 1.4× 68 1.5× 38 0.8× 14 278
Jodie Ulaszek United States 6 66 0.6× 106 1.0× 47 0.6× 154 3.4× 64 1.4× 9 329
Chantal Cognot France 7 140 1.3× 68 0.6× 24 0.3× 106 2.4× 41 0.9× 13 312
F. G. C. Jones United Kingdom 11 49 0.5× 122 1.2× 82 1.0× 128 2.8× 39 0.9× 18 289
Ania Manson United Kingdom 8 60 0.6× 45 0.4× 80 1.0× 57 1.3× 16 0.4× 11 254
M Vail United States 7 148 1.4× 144 1.4× 32 0.4× 38 0.8× 44 1.0× 7 339
Dharmvir S. Verma United States 12 102 0.9× 224 2.1× 103 1.3× 80 1.8× 50 1.1× 19 392
S. Fenu Italy 9 95 0.9× 301 2.8× 54 0.7× 127 2.8× 45 1.0× 20 367
J. L. Chertkov Russia 12 62 0.6× 146 1.4× 114 1.4× 140 3.1× 54 1.2× 37 323

Countries citing papers authored by D. W. Galvani

Since Specialization
Citations

This map shows the geographic impact of D. W. Galvani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. W. Galvani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. W. Galvani more than expected).

Fields of papers citing papers by D. W. Galvani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. W. Galvani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. W. Galvani. The network helps show where D. W. Galvani may publish in the future.

Co-authorship network of co-authors of D. W. Galvani

This figure shows the co-authorship network connecting the top 25 collaborators of D. W. Galvani. A scholar is included among the top collaborators of D. W. Galvani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. W. Galvani. D. W. Galvani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Simon G., Peter D. Currie, & D. W. Galvani. (2003). A complication of hip surgery. Postgraduate Medical Journal. 79(931). 300–300.
2.
Galvani, D. W., et al.. (1998). INCORRECT DIAGNOSIS OF DIABETES MELLITUS IN A PATIENT WITH PERSISTENCE OF FETAL HAEMOGLOBIN. International Journal of Clinical Practice. 52(7). 511–512. 1 indexed citations
3.
Delikat, Sylvie, D. W. Galvani, & Mirko Zuzel. (1995). The metabolic effects of interleukin 1β on human bone marrow adipocytes. Cytokine. 7(4). 338–343. 12 indexed citations
4.
Lowe, Gordon, Yushe Dang, Fiona L. Watson, Steven W. Edwards, & D. W. Galvani. (1994). Identification of a subgroup of myelodysplastic patients with a neutrophil stimulation‐signalling defect. British Journal of Haematology. 86(4). 761–766. 9 indexed citations
5.
Delikat, Sylvie, D. W. Galvani, & Mirko Zuzel. (1994). A function of CD10 on bone marrow stroma. British Journal of Haematology. 87(3). 655–657. 12 indexed citations
6.
Delikat, Sylvie, Ross Harris, & D. W. Galvani. (1993). IL-1 beta inhibits adipocyte formation in human long-term bone marrow culture.. PubMed. 21(1). 31–7. 17 indexed citations
7.
Pirmohamed, Munir, et al.. (1993). LACK OF INTERACTION BETWEEN SULPHASALAZINE AND CIMETIDINE IN PATIENTS WITH RHEUMATOID ARTHRITIS. Lara D. Veeken. 32(3). 222–226. 5 indexed citations
8.
Dang, Yushe, Gordon Lowe, Steven W. Edwards, & D. W. Galvani. (1993). The effects of GM-CSF on myeloperoxidase release in normal and myelodysplastic neutrophils. Leukemia Research. 17(12). 1037–1044. 13 indexed citations
9.
Giles, Francis J., C. P. Worman, A. V. Hoffbrand, et al.. (1993). Recombinant interferon alfa 2 a in the treatment of patients with early stage B chronic lymphocytic leukaemia. British Journal of Haematology. 85(1). 77–83. 21 indexed citations
10.
Galvani, D. W., et al.. (1992). Endolymphatic delivery of IL2 in patients with melanoma and lymphoma. Biotherapy. 4(4). 251–255. 4 indexed citations
11.
Galvani, D. W., Yushe Dang, Fiona L. Watson, et al.. (1992). Combination of GM-CSF and Cytosine in Myelodysplasia Results in Improved Neutrophil Function. Acta Haematologica. 87(3). 129–135. 5 indexed citations
12.
Galvani, D. W.. (1991). The Current Status of Myeloid Growth Factor Therapy. Journal of the Royal College of Physicians of London. 25(3). 213–217. 1 indexed citations
13.
Galvani, D. W.. (1990). Why Does α-Interferon Work in Chronic Granulocytic; Leukaemia?. Leukemia & lymphoma. 1(3-4). 175–178. 4 indexed citations
14.
Galvani, D. W. & John C. Cawley. (1990). The current status of interferonα in haemic malignancy. Blood Reviews. 4(3). 175–180. 10 indexed citations
15.
Galvani, D. W., et al.. (1990). γIFN receptor expression in haemic malignancies. Leukemia Research. 14(7). 657–660. 3 indexed citations
16.
Galvani, D. W., et al.. (1989). The beneficial effects of αIFN in CGL are probably not mediated by NK cells. British Journal of Haematology. 71(2). 233–237. 13 indexed citations
17.
Galvani, D. W. & John C. Cawley. (1989). Mechanism of action of α interferon in chronic granulocytic leukaemia: evidence for preferential inhibition of late progenitors. British Journal of Haematology. 73(4). 475–479. 35 indexed citations
18.
Galvani, D. W.. (1988). Cytokines: Biological Function and Clinical Use. Journal of the Royal College of Physicians of London. 22(4). 226–231. 3 indexed citations
19.
Galvani, D. W., Simon Griffiths, & John C. Cawley. (1988). Regular Review: Interferon for treatment: the dust settles. BMJ. 296(6636). 1554–1556. 17 indexed citations
20.
Galvani, D. W., A.B.W. Nethersell, & John C. Cawley. (1988). α-interferon in myelodysplasia; Clinical observations and effects on nk cells. Leukemia Research. 12(3). 257–262. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Teramura Breakdown of academic impact, for papers by Alexander Sternberg Breakdown of academic impact, for papers by Jodie Ulaszek Breakdown of academic impact, for papers by Chantal Cognot Breakdown of academic impact, for papers by F. G. C. Jones Breakdown of academic impact, for papers by Ania Manson Breakdown of academic impact, for papers by M Vail Breakdown of academic impact, for papers by Dharmvir S. Verma Breakdown of academic impact, for papers by S. Fenu Breakdown of academic impact, for papers by J. L. Chertkov
Rankless by CCL
2026